Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VR-AD-1005 for Acute Watery Diarrhea in Cholera
NCT06193408Phase 2Completed
- Sponsor
- Hunazine Biotech
- Start
- Feb 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VR-AD-1005 in cholera, sponsored by Hunazine Biotech. Started Feb 2024; status: completed.
02
Drugs
VR-AD-1005
03
Conditions
cholera
Beyond the preview
Go deeper on NCT06193408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06193408.